Join Andelyn’s Newsletter

Your Source for Quality Insights on Cell and Gene Therapies

We are committed to advancing the future of cell and gene therapies. By subscribing to our newsletter, you’ll receive:

Expert perspectives on the latest industry developments

Educational content on therapies from concept to commercialization

Exclusive insights into our pioneering work in rare diseases

Updates on conference attendance and technical presentations

News & Press Releases

News

May 18, 2026

Manufacturing Chemist | Andelyn Biosciences strengthens CDMO credentials with full ICMC certification Manufacturing Chemist | Andelyn Biosciences strengthens CDMO credentials with full ICMC certification

Press Release

May 13, 2026

Andelyn Biosciences Receives Dark Horse Consulting Certification of Gene Therapy Manufacturing Systems and Capabilities within its Initiative for Certification of Manufacturing Capabilities (ICMC™) Program Andelyn Biosciences Receives Dark Horse Consulting Certification of Gene Therapy Manufacturing Systems and Capabilities within its Initiative for Certification of Manufacturing Capabilities (ICMC™) Program

Press Release

May 11, 2026

Andelyn Biosciences Launches LVV Curator® Platform, Bringing Proven Viral Vector Platform Pedigree to Lentiviral Vector Manufacturing for Cell Therapies Andelyn Biosciences Launches LVV Curator® Platform, Bringing Proven Viral Vector Platform Pedigree to Lentiviral Vector Manufacturing for Cell Therapies

News

April 24, 2026

Manufacturing Chemist | Andelyn Biosciences and ENCell partner to create US-APAC gene therapy manufacturing corridor Manufacturing Chemist | Andelyn Biosciences and ENCell partner to create US-APAC gene therapy manufacturing corridor

View All News & Press Releases

By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.

Preferences Deny Accept